Research

Research

Areas of Study

Melanoma Risk

Melanoma Risk

Cust et al, 2020, A risk prediction model for the development of subsequent primary melanoma in a population-based cohort (PMID 31520533)

Yardman-Frank et al, 2021, Differences in Melanoma Between Canada and New South Wales, Australia: A Population-Based Genes, Environment, and Melanoma (GEM) Study (PMID 33768212)

Read More
Pathoepidemiology & Molecular Pathoepidemiology

Pathoepidemiology & Molecular Pathoepidemiology

Thomas et al, 2013, Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study (PMID 24127443)

Yardman-Frank et al, 2021, Comparison of community pathologists with expert dermatopathologists evaluating Breslow thickness and histopathologic subtype in a large international population-based study of melanoma (PMID 34409386)

Read More
Melanoma Survival

Melanoma Survival

Taylor et al, 2016, Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma (PMID 27101944)

Murali et al, 2025, Sex differences in melanoma survival: a GEM study (PMID 39799507)

Read More
Communication & Behavioral Risk Reduction

Communication & Behavioral Risk Reduction

Zapolska et al, 2016, Patterns and sources of information about family melanoma risk among melanoma survivors (PMID 30190879)

Hay et al, 2024, Exploring the role of cancer fatalism and engagement with skin cancer genetic information in diverse primary care patients (PMID 38546209)

Read More
Methodological

Methodological

Vicory et al, 2015, Appearance normalization of histology slides (PMID 25863518)

Mauguen et al, 2017, Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma (PMID 28603323)

Read More

Grants and Awards

A model for genetic susceptibility: melanoma

U01 CA83180-01 NIH (Berwick)

Solar exposure and melanoma survival

R01 CA112524 NIH (Berwick)

Mutational analysis of clonality in multiple primary melanoma

R03 CA125829 NIH (Orlow)

Melanoma RAS/BRAF mutation: heterogeneity-risk-prognosis

R01 CA112243 NIH/NC (Thomas)

Validation of the use of whole-genome amplified DNA in a population-based study

R03 CA173806 NIH/NCI (Orlow)

Identification of Lethal Melanoma at the Time of Diagnosis

*R01 CA233524 NIH/NCI (Thomas, Begg, Berwick)

*current support

Epi Questionnaire

Access the GEM study Epidemiological Questionnaire